Medication adherence – key considerations for clinical pharmacologists
Research output: Contribution to journal › Editorial › peer-review
Standard Standard
Medication adherence – key considerations for clinical pharmacologists. / Hughes, Dyfrig.
In: British Journal of Clinical Pharmacology, Vol. 86, No. 4, 04.2020, p. 628-629 .
In: British Journal of Clinical Pharmacology, Vol. 86, No. 4, 04.2020, p. 628-629 .
Research output: Contribution to journal › Editorial › peer-review
HarvardHarvard
Hughes, D 2020, 'Medication adherence – key considerations for clinical pharmacologists', British Journal of Clinical Pharmacology, vol. 86, no. 4, pp. 628-629 . https://doi.org/10.1111/bcp.14228
APA
Hughes, D. (2020). Medication adherence – key considerations for clinical pharmacologists. British Journal of Clinical Pharmacology, 86(4), 628-629 . https://doi.org/10.1111/bcp.14228
CBE
Hughes D. 2020. Medication adherence – key considerations for clinical pharmacologists. British Journal of Clinical Pharmacology. 86(4):628-629 . https://doi.org/10.1111/bcp.14228
MLA
Hughes, Dyfrig. "Medication adherence – key considerations for clinical pharmacologists". British Journal of Clinical Pharmacology. 2020, 86(4). 628-629 . https://doi.org/10.1111/bcp.14228
VancouverVancouver
Hughes D. Medication adherence – key considerations for clinical pharmacologists. British Journal of Clinical Pharmacology. 2020 Apr;86(4):628-629 . Epub 2020 Feb 25. doi: 10.1111/bcp.14228
Author
RIS
TY - JOUR
T1 - Medication adherence – key considerations for clinical pharmacologists
AU - Hughes, Dyfrig
PY - 2020/4
Y1 - 2020/4
U2 - 10.1111/bcp.14228
DO - 10.1111/bcp.14228
M3 - Editorial
C2 - 32100316
VL - 86
SP - 628
EP - 629
JO - British Journal of Clinical Pharmacology
JF - British Journal of Clinical Pharmacology
SN - 1365-2125
IS - 4
ER -